Have a personal or library account? Click to login
The Rh blood group system: additional complexities Cover

The Rh blood group system: additional complexities

By: P.D. Issitt  
Paid access
|Nov 2020

References

  1. Levine P, Stetson RE. An unusual case of intragroup agglutination. J Am Med Assoc 1939;113:126–7.10.1001/jama.1939.72800270002007a
  2. Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol NY 1940;43:223.10.3181/00379727-43-11151
  3. Grove-Rasmussen M. Routine compatibility testing standards of the AABB as applied to compatibility tests. Transfusion 1964; 4:200–5.10.1111/j.1537-2995.1964.tb02859.x
  4. Tovey GH. Preventing the incompatible blood transfusion. Haematologia 1974;8:389–91.
  5. Issitt PD. Clinical consequences and practical limitations of Rh-negative blood transfusion. In: Smit Sibinga C, Ed. Proc of a Symposium on the Rh blood group system. Groningen: Netherlands Red Cross Blood Center, 1979:46–63.
  6. Issitt PD, Pavone BG, Goldfinger D, et al. Anti-Wrb and other autoantibodies responsible for positive direct antiglobulin tests in 150 individuals. BrJ Haematol 1976;34:5–18.10.1111/j.1365-2141.1976.tb00168.x
  7. Lomas C, Grassmann W, Ford D, et al. FPTT is a low incidence Rh antigen associated with a “new” partial Rh D phenotype, DFR. Transfusion 1994;34:612–6.10.1046/j.1537-2995.1994.34794330017.x
  8. Sistonen P, Sareneva H, Pirkola A, Eklund J. MAR, a novel high incidence Rh antigen revealing the existence of an allelic subsystem including CW(Rh8) and CX(Rh9) with exceptional distribution in the Finnish population. Vox Sang 1994;66:287–92.
  9. Lewis M, Anstee DJ, Bird GWG, et al. Blood group terminology 1990. Vox Sang 1990;58:152–69.10.1159/000461106
  10. Lomas C, McColl K. Tippett P. Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transfus Med 1993;3:67–9.10.1111/j.1365-3148.1993.tb00106.x
  11. Lomas C, Tippett P, Mannessier L. Abolition of the DVc subcategory (letter). Transfusion 1993;33:535–6.10.1046/j.1537-2995.1993.33693296822.x
  12. Tippett P. Subdivisions of the Rh(D) antigen. Med Lab Sci 1988;45:88–93.
  13. Scott ML, Voak D, Jones J, Campbell G. An example of an Rh D variant whose reaction pattern with monoclonal antibodies splits epitope D6/7 and subsplits epitope D2 (abstract). Transfus Med 1994;4(suppl 1):45.
  14. Moore S, Woodrow CF, McClelland DBL. Isolation of membrane components associated with human red cell antigens Rh(D), (c), (E), and Fya. Nature 1982;295:529–31.10.1038/295529a0
  15. Gahmberg CG. Molecular identification of the human Rho(D) antigen. FEBS Lett 1982;140:93–7.10.1016/0014-5793(82)80528-0
  16. Colin Y, Bailly P, Cartron J-P. Molecular genetic basis of Rh and LW blood groups. Vox Sang 1994;67(suppl 3):67–72.10.1159/000462704
  17. Anstee DJ, Mallinson G. The biochemistry of blood group antigens—some recent advances. Vox Sang 1994;67(suppl 3):1–6.10.1159/000462694
  18. Issitt PD. The Rh blood group system: from clumps to clones (editorial). Transfusion 1994;34:462–3.10.1046/j.1537-2995.1994.34694295058.x8023385
  19. Byrne PC, Howard JH. The incidence of V (Rh10) and Jsa (K6) in the contemporary African American blood donor. Immunohematology 1994;10:136–8.10.21307/immunohematology-2019-941
  20. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431
  21. Sosler SD, Perkins JT, Saporito C, et al. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease (abstract). Transfusion 1989;29(suppl 7S):49S.10.1046/j.1537-2995.1989.29589284154.x2734828
  22. DeNatale A, Cahan A, Jack JA, Race RR, Sanger R. V, a “new” Rh antigen, common in Negroes and rare in white people. J Am Med Assoc 1955;159:247–50.
  23. Issitt PD. Applied blood group serology. 3rd ed. Miami: Montgomery Scientific Publications, 1985.
  24. Devenish A, Kay LA. Hemolytic transfusion reactions due to anti-e+f detectable only by nonstandard serologic techniques. Immunohematology 1994;10:120–3.10.21307/immunohematology-2019-936
  25. Issitt PD, Combs MR, Bredehoeft SJ, et al. Lack of clinical significance of “enzyme-only” red cell alloantibodies. Transfusion 1993;33:284–93.10.1046/j.1537-2995.1993.33493242634.x8480348
  26. Lalezari P, Jiang AF. The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies. Transfusion 1980;20:206–11.10.1046/j.1537-2995.1980.20280169962.x6768173
  27. Pickles MM, Jones MN, Egan J, Dodsworth H, Mollison PL. Delayed haemolytic transfusion reactions due to anti-C. Vox Sang 1978;35:32–5.10.1111/j.1423-0410.1978.tb02897.x96602
  28. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th Ed. Oxford: Blackwell Scientific Publications, 1993.
  29. Kugele F, Carney M, Oliver C, Hollander J. Case report: IgG1 Rh antibodies causing moderate hemolytic disease of the newborn. Immunohematology 1994;10:124–6.10.21307/immunohematology-2019-937
  30. Bowell PJ, Wainscot JS, Peto TEA, Gunson HH. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn. Br Med J 1982;285:327–9.10.1136/bmj.285.6338.327
  31. Bowell PJ. Reproducibility studies on the automated anti-D quantitation method: preliminary report on the U.K. quality control studies. Plasma Therap Transfus Technol 1984;5: 73-80.
  32. Report from nine collaborating laboratories. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Vox Sang 1991;60:225–9.10.1159/000461292
  33. Engelfriet CP, Ouwehand WH. ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. Ballieres Clin Haematol 1990;3:321–37.10.1016/S0950-3536(05)80053-8
  34. Hadley AC, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative, and cell-mediated functional assays of maternal antibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991;77:221–8.10.1111/j.1365-2141.1991.tb07981.x2004024
  35. Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of the newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23:91–4.10.1046/j.1537-2995.1983.23283172867.x6404025
  36. Devenish A. An example of anti-LWa in a 10-month-old infant. Immunohematology 1994;10:127–9.10.21307/immunohematology-2019-938
  37. Garratty G. Do blood groups have a biological role? In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994:201–55.
  38. Tregellas WM, Moulds JJ, South SF. Successful transfusion of a patient with anti-LW and LW positive blood (abstract). Transfusion 1978;18:384.
  39. Cummings E, Pisciotto P, Roth G. Normal survival of Rho(D) negative, LW(a+) red cells in a patient with allo-anti-LWa. Vox Sang 1984;46:286–90.
  40. Chaplin H, Hunter VL, Rosche ME, Shirey RS. Long term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW. Transfusion 1984;25:39–43.10.1046/j.1537-2995.1985.25185116500.x3918363
  41. Johnson ST, Davis HL, Gottschall JL. Successful transfusion of Rh positive, LW positive blood to a patient with anti-LWab (abstract). Transfusion 1992;32(suppl 8S):53S.
  42. Marsh WL, Nichols ME, Øyen R, et al. Naturally-occurring anti-Kell stimulated by E. coli enterocolitis in a 20-day-old child. Transfusion 1978;18:149–54.10.1046/j.1537-2995.1978.18278160576.x347643
  43. Kao YS, Frank S, DeJongh DS. Anti-M in children with acute bacterial infections. Transfusion 1978;18:320–2.10.1046/j.1537-2995.1978.18378205140.x351884
  44. McGinniss MH. The ubiquitous nature of human blood group antigens as evidenced by bacterial, viral, and parasitic infections. In: Garratty G, ed. Blood group antigens and disease. Arlington, VA: American Association of Blood Banks, 1983:25–43.
  45. Konigshaus GJ, Holland TI. The effects of dithiothreitol on the LW antigen. Transfusion 1984;24:536–7.10.1046/j.1537-2995.1984.24685066821.x
  46. Mallinson G, Martin PG, Anstee DJ, et al. Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood group system. Biochem J 1986;234:649–52.10.1042/bj2340649
  47. Mohandas K, Najfield V, Gilbert H, Azar P, Skerrett D. Loss and reappearance of Rho(D) antigen on the red blood cells of an individual with acute myelogenous leukemia. Immunohematology 1994;10:134–5.10.21307/immunohematology-2019-940
  48. Ruddle F, Ricciuti F, McMorris FA, et al. Somatic cell genetic assignment of peptidase C and the Rh linkage group to chromosome A-1 in man. Science 1972;176:1429–31.10.1126/science.176.4042.1429
  49. Marsh WL, Chaganti RSK, Gardner FH, et al. Mapping human autosomes: evidence supporting assignment of Rhesus to the short arm of chromosome no. 1. Science 1974;183:966–8.10.1126/science.183.4128.966
  50. Cherif-Zahar B, Mattei MG, Le Van Kim C, et al. Localization of the human Rh blood group gene structure to chromosome region 1p34.3 – 1p36.1 by in situ hybridization. Hum Genet 1991;86:398–400.
  51. Lewis M, Anstee DJ, Bird GWG, et al. ISBT working party on terminology for red cell surface antigens: Los Angeles report. Vox Sang 1991;61:158–60.10.1159/000461346
  52. Zelinski T. The use of DNA restriction fragment length polymorphisms in conjunction with blood group serology. Transfusion 1991;31:762–70.10.1046/j.1537-2995.1991.31892023506.x
  53. Daniels GL, Moulds JJ, Anstee DJ, et al. ISBT working party on terminology for red cell surface antigens: Sao Paulo Report. Vox Sang 1993;65:77–80.10.1111/j.1423-0410.1993.tb04534.x
  54. Storry JR, Gorman M, Maddox NI, Toy E, Issitt PD, Mallory D. First example of Rh:–32,–46 red cell phenotype. Immunohematology 1994;10:130–3.10.21307/immunohematology-2019-939
  55. Allen FH Jr, Corcoran PA. Evidence for a new blood group antigen of nearly universal occurrence (abstract). Prog 11th Annual Meeting, American Association of Blood Banks, Cincinnati, 1958.
  56. Moore BPL, Cornwall S, Crockford J, Vos GH. The immune response in D––, DCW– and Dc– homozygotes (abstract). Proc 14th Cong, Int Soc Blood Transfus 1975:58.
  57. Rosenfield RE. The complexity of the Rh blood group system as revealed by unusual instances of isoimmunization. Unpublished manuscript 1960 cited in reference 24.
  58. Shapiro M. Serology and genetics of a new blood factor: hr3. J Forens Med 1960;7:96–105.
  59. Shapiro M, LeRoux M, Brink S. Serology and genetics of a new blood factor: hrB. Haematologia 1972;6:121–8.
  60. Salmon C, Gerbal A, Liberge E, et al. Le complexe genique DIV(C)–. Rev Franc Transfus 1969;12:239-47 (in French).10.1016/S0035-2977(69)80066-0
  61. Perrier P, Habibi B, Salmon C. Alloantibodies in partially silent Rh phenotypes. Evidence for a possibly new high frequency Rh antigen. Blood Transfus Immunohematol 1981;23:327–9.10.1016/S0338-4535(80)80136-X
  62. Habibi B, Perrier P, Salmon C. Antigen Nou: A new high frequency Rh antigen. Blood Transfus Immunohematol 1981;24: 117-20.10.1016/S0338-4535(81)80032-3
  63. Contreras M, Stebbing B, Blessing M, et al. The Rh antigen Evans. Vox Sang 1978;34:208–11.10.1111/j.1423-0410.1978.tb02469.x
  64. Daniels GL. Blood group antigens of high frequency: a serological and genetical study. PhD Thesis, Univ London, England, 1980.
  65. Daniels GL. An investigation of the immune response of homozygotes for the Rh haplotype –D– and related haplotypes. Blood Transfus Immunohematol 1982;25:185–97.10.1016/S0338-4535(82)80007-X
  66. Issitt PD. An invited review: the Rh antigen e, its variants, and some closely related serological observations. Immunohematology 1991;7:29–36.10.21307/immunohematology-2019-1007
  67. Le Pennec PY, Rouger P, Klein MT, et al. A serologic study of red cells and sera from 18 Rh:32,–46 (RN/RN) persons. Transfusion 1989;29:798–802.10.1046/j.1537-2995.1989.29990070185.x
  68. Rosenfield RE, Haber GV, Schroeder R, Ballard R. Problems in Rh typing as revealed by a single Negro family. Am J Hum Genet 1960;12:147–59.
  69. Chown B, Lewis M, Kaita H. The Rh system. An anomaly of inheritance, probably due to mutation. Vox Sang 1971;21:385–96.10.1111/j.1423-0410.1971.tb04794.x
  70. Chown B, Allen FH Jr, Cleghorn TE, et al. Unpublished observations 1965-1968, cited by Race RR, Sanger R. In: Blood groups in man. 5th ed. Oxford: Blackwell Scientific Publications, 1968:209.
  71. Issitt PD, Gutgsell NS, McDowell MA, Tregellas WM. Studies on anti-Rh46 (abstract). Blood 1987;70 (suppl 1): 110a.
  72. Issitt PD, Gutgsell NS. Some new Rh antigens: Rh43 to Rh47. Immunohematology 1987;3:1–6.10.21307/immunohematology-2019-1118
  73. Issitt PD. The Rh blood group system, 1988: eight new antigens in nine years and some observations on the biochemistry and genetics of the system. Transfus Med Rev 1989;3:1–12.10.1016/S0887-7963(89)70064-X
  74. Dzik W, Blank J, Lutz P, Hirose TG, Lomas C, Moulds M. Autoimmune hemolysis following transfusion: a mimicking autoanti-D in a D-negative patient with alloanti-D. Immunohematology 1994;10:117–9.10.21307/immunohematology-2019-935
  75. Polesky HF, Bove JR. A fatal hemolytic transfusion reaction with acute autohemolysis. Transfusion 1964;4:285–92.10.1111/j.1537-2995.1964.tb02874.x14177382
  76. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions: evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984;24:188–93.10.1046/j.1537-2995.1984.24384225018.x6610232
  77. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long term serologic findings, and clinical significance. Transfusion 1990;30:688–93.10.1046/j.1537-2995.1990.30891020325.x2219254
  78. Shirey RS, Ness PM. New concepts of delayed hemolytic transfusion reactions. In: Nance SJ, ed. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks, 1991;179–97.
  79. Issitt PD, Zellner DC, Rolih SD, Duckett JB. Autoantibodies mimicking alloantibodies. Transfusion 1977;17:531–8.10.1046/j.1537-2995.1977.17678075647.x413221
  80. Henry RA, Weber J, Pavone BG, Issitt PD. A “normal” individual with a positive direct antiglobulin test. Case complicated by pregnancy and unusual autoantibody specificity. Transfusion 1977;17:539–46.10.1046/j.1537-2995.1977.17678075648.x413222
  81. Issitt PD, Pavone BG. Critical reexamination of the specificity of auto-anti-Rh antibodies in patients with a positive direct antiglobulin test. Br J Haematol 1978;38:63–74.10.1111/j.1365-2141.1978.tb07109.x416845
  82. Weiner W, Vos GH. Serology of acquired hemolytic anemias. Blood 1963;22:606–13.10.1182/blood.V22.5.606.606
  83. Issitt PD, Wren MR, McDowell MA, et al. Anti-Rh33, the second separable example, also made by a person who made anti-D and has C+ red cells. Transfusion 1986;26:506–10.10.1046/j.1537-2995.1986.26687043614.x3095959
  84. Weber J, Caceres VW, Pavone BG, Issitt PD. Allo-anti-C in a patient who had previously made an autoantibody mimicking anti-C. Transfusion 1979;19:216–8.10.1046/j.1537-2995.1979.19279160298.x86216
  85. Mollison PL, Crome P, Hughes-Jones NC, Rochna E. Rate of removal from the circulation of red cells sensitized with different amounts of antibody. Br J Haematol 1965;11:461–70.10.1111/j.1365-2141.1965.tb06609.x14317439
  86. Mouro I, Colin Y, Cherif-Zahar B, Cartron J-P, Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nature Genetics 1993;5:62–5.10.1038/ng0993-628220426
DOI: https://doi.org/10.21307/immunohematology-2019-934 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 109 - 116
Published on: Nov 30, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 P.D. Issitt, published by American National Red Cross
This work is licensed under the Creative Commons License.